These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26616888)

  • 21. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis.
    Álvarez-Velasco R; Gutiérrez-Gutiérrez G; Trujillo JC; Martínez E; Segovia S; Arribas-Velasco M; Fernández G; Paradas C; Vélez-Gómez B; Casasnovas C; Nedkova V; Guerrero-Sola A; Ramos-Fransi A; Martínez-Piñeiro A; Pardo J; Sevilla T; Gómez-Caravaca MT; López de Munain A; Jericó I; Pelayo-Negro AL; Martín MA; Morgado Y; Mendoza MD; Pérez-Pérez H; Rojas-García R; Turon-Sans J; Querol L; Gallardo E; Illa I; Cortés-Vicente E
    Eur J Neurol; 2021 Jun; 28(6):2083-2091. PubMed ID: 33721382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonthymoma early-onset- and late-onset-generalized myasthenia gravis--a retrospective hospital-based study.
    Chan KH; Cheung RT; Mak W; Ho SL
    Clin Neurol Neurosurg; 2007 Oct; 109(8):686-91. PubMed ID: 17644246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and outcomes of eculizumab for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.
    Suh J; Clarke V; Amato AA; Guidon AC
    Muscle Nerve; 2022 Sep; 66(3):348-353. PubMed ID: 35684980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes.
    Huang Q; Li F; Zhao S
    BMC Neurol; 2022 Mar; 22(1):73. PubMed ID: 35246057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymoma pathology and myasthenia gravis outcomes.
    Menon D; Katzberg H; Barnett C; Pal P; Bezjak A; Keshavjee S; Bril V
    Muscle Nerve; 2021 Jun; 63(6):868-873. PubMed ID: 33675078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between clinical manifestation, prognosis and antibody in anti-muscle-specific tyrosine kinase antibody positive myasthenia gravis].
    Tan Y; Zhu L; Huang YY; Shi JY; Li J; Li K; Guan YZ; Cui LY
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2433-2437. PubMed ID: 34399555
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myasthenia gravis (MG): epidemiological data and prognostic factors.
    Mantegazza R; Baggi F; Antozzi C; Confalonieri P; Morandi L; Bernasconi P; Andreetta F; Simoncini O; Campanella A; Beghi E; Cornelio F
    Ann N Y Acad Sci; 2003 Sep; 998():413-23. PubMed ID: 14592909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenia gravis: presentation and outcome in 104 patients managed in a single institution.
    Al-Moallem MA; Alkali NH; Hakami MA; Zaidan RM
    Ann Saudi Med; 2008; 28(5):341-5. PubMed ID: 18779641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients.
    Bachmann K; Burkhardt D; Schreiter I; Kaifi J; Busch C; Thayssen G; Izbicki JR; Strate T
    Surg Endosc; 2008 Nov; 22(11):2470-7. PubMed ID: 18297352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.
    Mantegazza R; Wolfe GI; Muppidi S; Wiendl H; Fujita KP; O'Brien FL; Booth HDE; Howard JF;
    Neurology; 2021 Jan; 96(4):e610-e618. PubMed ID: 33229455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of post-thymectomy long-term neurological remission in thymomatous myasthenia gravis: an analysis from a multi-institutional database.
    Na KJ; Hyun K; Kang CH; Park S; Lee HJ; Park IK; Kim YT; Lee GD; Kim HR; Choi SH; Kim YH; Kim DK; Park SI; Shin S; Cho JH; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
    Eur J Cardiothorac Surg; 2020 May; 57(5):867-873. PubMed ID: 31859338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis.
    Robeson KR; Kumar A; Keung B; DiCapua DB; Grodinsky E; Patwa HS; Stathopoulos PA; Goldstein JM; O'Connor KC; Nowak RJ
    JAMA Neurol; 2017 Jan; 74(1):60-66. PubMed ID: 27893014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes.
    Keijzers M; de Baets M; Hochstenbag M; Abdul-Hamid M; Zur Hausen A; van der Linden M; Kuks J; Verschuuren J; Kessels F; Dingemans AM; Maessen J
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):40-5. PubMed ID: 25234092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of eculizumab in ventilator-dependent myasthenia gravis patients.
    Usman U; Chrisman C; Houston D; Haws CC; Wang A; Muley S
    Muscle Nerve; 2021 Aug; 64(2):212-215. PubMed ID: 34008175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
    Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
    BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.
    Pompeo E; Tacconi F; Massa R; Mineo D; Nahmias S; Mineo TC
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):164-9. PubMed ID: 19339195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study.
    Lin J; Li Y; Gui M; Bu B; Li Z
    Ther Adv Neurol Disord; 2024; 17():17562864241251476. PubMed ID: 38751755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis.
    Vijayan J; Menon D; Barnett C; Katzberg H; Lovblom LE; Bril V
    Muscle Nerve; 2021 Oct; 64(4):462-466. PubMed ID: 34235762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robotic-Extended Rethymectomy for Refractory Myasthenia Gravis: A Case Series.
    Li F; Li Z; Takahashi R; Ioannis A; Ismail M; Meisel A; Rueckert JC
    Semin Thorac Cardiovasc Surg; 2020 Autumn; 32(3):593-602. PubMed ID: 31682904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.